Product logins

Find logins to all Clarivate products below.


Neurovascular Devices | Market Insights | Asia Pacific | 2021

Despite the short-term impact of the COVID-19 pandemic, as well as barriers to patients’ access to neurovascular treatments, improving healthcare infrastructure, growing demand, and clinical data supporting the endovascular approach over surgical interventions for treating neurovascular diseases will support procedure volume growth in Asia Pacific countries.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Neurovascular devices in Asia Pacific across a 10-year period.

Related Medtech Insights Reports

Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…